Ligand Binding Induces Agonistic-Like Conformational Adaptations in Helix 12 of Progesterone Receptor Ligand Binding Domain

Liangzhen Zheng, Kelin Xia, Yuguang MuFrontiers in Chemistry 2019 · DOI

TL;DR

This study uses molecular dynamics simulations to reveal how progesterone receptor (PR) ligand binding domain (LBD) undergoes conformational changes, particularly in helix 12. The findings show that both agonists and selective progesterone receptor modulators (SPRMs) induce "closed" (agonistic-like) conformations, but SPRM-bound complexes are less stable, explaining their partial agonism. Co-repressor peptides, however, stabilize a "semi-open" state.

What Problem Does This Paper Address?

The progesterone receptor (PR) is a crucial nuclear receptor involved in female reproductive health and implicated in various cancers. Understanding how its ligand-binding domain (LBD) changes shape upon binding to different molecules (agonists, antagonists, or selective modulators) is vital for both understanding its biological function and developing targeted therapies. A key unanswered question has been the precise mechanism by which ligands, especially selective modulators (SPRMs), induce these conformational shifts, particularly the dynamic behavior of helix 12, a critical component for receptor activation. Previous structural studies often captured static snapshots, leaving the dynamic transitions and their functional implications unclear.

Methods

The researchers employed molecular dynamics (MD) simulations to investigate the conformational dynamics of the PR LBD. They simulated various systems: the apo-form (unliganded) PR LBD, PR LBD bound to the agonist progesterone (P4), PR LBD bound to the SPRM asoprisnil, and PR LBD in complex with co-repressor peptides. These simulations, run on GPU-accelerated hardware for microsecond timescales, allowed them to observe how the protein structure evolved over time. They analyzed these dynamics using:

  • Root Mean Square Deviation (RMSD) and Root Mean Square Fluctuation (RMSF) to assess overall structural stability and residue flexibility.
  • Principal Component Analysis (PCA) to identify dominant modes of conformational change.
  • aC RMSD (ARMSD), a metric specifically developed to quantify the deviation from known "open" and "closed" states, to track the transition between these conformations.
  • Clustering analysis to identify representative structural states.
  • Quasi-Harmonic conformational entropy calculations to quantify flexibility.

Datasets

The study utilized existing crystal structures of the PR LBD from the RCSB Protein Data Bank (PDB) as starting points for their simulations. These structures included:

  • PDB ID: 1A28 (agonist-bound PR LBD)
  • PDB ID: 2OVH (antagonist-bound PR LBD)

No new datasets or benchmarks were introduced in this paper.

Key Insights and Ideas

  • Agonist binding stabilizes the LBD: Progesterone (P4) binding significantly reduces the flexibility of the PR LBD, particularly in regions around helices 5-7, 11, and 12, and associated loops. This stabilization is reflected in lower configurational entropy for the liganded state.
  • Helix 12 adopts an agonistic "closed" state with SPRMs: Surprisingly, SPRMs like asoprisnil also induce helix 12 to adopt a "closed" conformation, similar to that seen with agonists. This suggests that SPRMs can initiate the basic structural changes associated with activation.
  • SPRM-bound complexes are less stable: Despite inducing a "closed" conformation, the SPRM-bound PR LBD complex is less stable than the agonist-bound complex. This instability, particularly in helix 12 and the H11-H12 loop, is proposed to be the molecular basis for the partial agonism observed with SPRMs.
  • Co-repressor peptides stabilize a "semi-open" state: In the absence of a ligand, co-repressor peptides do not stabilize the "open" state but rather a "semi-open" state. This suggests they can act as a bridge, potentially interacting with both the LBD and other cellular machinery.
  • Ligand-induced conformational change is a multi-stage process: The transition from an "open" to a "closed" state involves a sequence of events: formation of a hydrophobic core, patching of helix 12 onto helix 3, and subsequent optimization of the H11-H12 loop.
  • Hydrophobic interactions and electrostatic forces are key drivers: The formation of hydrophobic clusters involving conserved residues and long-range electrostatic attractions between charged centers on helix 12 and helix 3 are identified as crucial forces driving the conformational reorientation.
  • Structural water molecules play a role: Conserved water molecules bridging key residues like W755 and V912 are observed and are proposed to contribute to the stability of the liganded PR LBD.

Key Results

  • MD simulations showed that P4 binding reduced the configurational entropy of the PR LBD from 1529.86 J/mol·K to 1230.43 J/mol·K, indicating increased stability.
  • Asoprisnil binding also induced a "closed" state, as evidenced by ARMSD values dropping significantly, though the H11-H12 loop remained more disordered compared to P4-bound simulations.
  • The simulations demonstrated that co-repressor peptides, when bound alone, did not lead to a stable "open" state but rather a "semi-open" conformation.
  • The study identified specific electrostatic interactions (e.g., between E723 and R899) and hydrophobic interactions that are critical for stabilizing the "closed" conformation.

Limitations and Future Work

  • Simulation timescale limitations: While microsecond simulations were performed, some very slow conformational transitions, such as the transition from an apo-form "closed" LBD to an "open" state, might occur on timescales beyond the scope of this study.
  • Mechanism of antagonism: The paper notes that while they observed the destabilization of the agonistic "closed" LBD with an antagonist, the precise mechanism by which antagonists achieve their effect and the transition from an apo-form "closed" to an "open" state remain to be fully elucidated.
  • SPRMs and co-activator/co-repressor interplay: The paper suggests a roadmap for PR LBD adaptation but acknowledges that the precise binding competition between co-repressors and co-activators, especially in the presence of SPRMs, requires further investigation.
  • Future work: The authors propose that further studies on the kinetics of conformational transitions are needed to fully understand the PR LBD conformational adaptation roadmap. Investigating the precise relationship between antagonism and conformational changes is also highlighted as a future direction.

Summary updated

Abstract

Progesterone receptor (PR) is a member of the nuclear receptor (NR) superfamily and plays a vital role in the female reproductive system. The malfunction of it would lead to several types of cancers. The understanding of conformational changes in its ligand binding domain (LBD) is valuable for both biological function studies and therapeutically intervenes. A key unsolved question is how the binding of a ligand (agonist, antagonist, or a selective modulator) induces conformational changes of PR LBD, especially its helix 12. We applied molecular dynamics (MD) simulations to explore the conformational adaptations of PR LBD with or without a ligand or the co-repressor peptides binding. From the simulations, both the agonist progesterone (P4) and the selective PR modulator (SPRM) asoprisnil induces agonistic-like helix 12 conformations (the "closed" states) in PR LBD and the complex of LBD-SPRM is less stable, comparing to the agonist-liganded PR LBD. The results, therefore, explain the partial agonism of the SPRM, which could induce weak agonistic effects in PR. We also found that co-repressor peptides could be stably associated with the LBD and stabilize the LBD in a "semi-open" state for helix 12. These findings would enhance our understanding of PR structural and functional relationships and would also be useful for future structure and knowledge-based drug discovery.
BibTeX
@inproceedings{zheng2019ligand,
  author = {Liangzhen Zheng and Kelin Xia and Yuguang Mu},
  title = {{Ligand Binding Induces Agonistic-Like Conformational Adaptations in Helix 12 of Progesterone Receptor Ligand Binding Domain}},
  booktitle = {Frontiers in Chemistry},
  year = {2019},
  doi = {10.3389/fchem.2019.00315},
}
Figure